LATEST ALERTS
The cannabinoid industry will not escape increased prices from US tariffs on imports.
Its primary products remain unaffected, with no tariffs levied on the international trade of medical cannabis or hemp-derived cannabinoid products. However, pretty much anything else used with cannabinoid products will increase in price – even with the pausing of the majority of “liberation day” tariffs on multiple US trade partners.
The remaining tariffs on Chinese imports into the US will have a massive impact on the price of cannabis goods on the US market, if tariffs on other import producers announced on liberation day are reinstated.
